All GLG News Analyses Filed Under: Orthopaedics
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
-
March 26, 2007
Think first about doing a THA procedure in patients with severe hip, low back pain | www.orthosupersite.com
The differential diagnosis of hip and spine has plagued orthopaedic surgeons for some time. Patients often present with both as not only can the pain be linked mechanically there are obvious neurologic reasons for someone with back problems to have referred pain to the hip. Hip arthroplasties have occurred in patients where the primary pathology was spinal to find upon awakening that the pain has not improved and vice versa. The gaint abnormalities that can come about with hip arthritis can exacerbate any pre-existing lumbar pathology therefore not surprising at the improvement noted in the article.
-
March 26, 2007
Unigene’s Site-Directed Bone Growth Technology May Have Multiple Large Market Applications According to New Market Analysis | home.businesswire.com
Vertebral compression fractures are a painful and deblilitating problem.
We will see an increase as the baby boomers move solidly into clinically significant osteoporosis...
Hip fracture also will increase for the same reason....although they do not have a high complication rate if the correct surgery is chosen to meet the pathology...overall 20% non-union for femoral neck fractures (more than likely surgeries that should have been hemiparthroplasties). 25% of patients die in first year after hip fracture
If we can truly impact above then there is a case for the product...if not...nice book end...
Non-union...can be tough to heal long bone non-unions..anything to help is helpful...other products available in this space...have to demonstrate significant clinical superiority...ease of use.... -
TOPS system is still a long way from becoming a relevant device in the US market
March 26, 2007
Impliant Receives CE Mark Approval For The TOPS-on-Fusion(TM) System, The First Integrated Motion Preservation System For Spinal Fusion Patients | www.medicalnewstoday.com
TOPS is one of a variety of devices designed to maintain motion across a diseased spinal segment. The data published is still quite short of convincing.
Inadequate outcome data and reimbursement challenges will be major hurdles for the success of this device in the US market. -
New alternative to multi-level fusions
March 21, 2007
Impliant Receives CE Mark Approval For The TOPS-on-Fusion(TM) System, The First Integrated Motion Preservation System For Spinal Fusion Patients | www.medicalnewstoday.com
The Impliant TOPS-on-Fusion (TM) device has received CE Mark approval.
The system allows the surgeon to avoid fusing 2 levels. -
Are we compromising the immune system?
March 2, 2007
FDA Approves Abbott's Humira for Treatment of Crohn's Disease | online.wsj.com
The annoying life style symptoms that accompany this drug, Humira, may only be tolerated if the disease is totally debilitating the patient.
The persistent cough and flu like symptoms I see my arthritis patients exhibiting, are tough to live with. -
February 9, 2007
Smith & Nephew says court upholds injunction against Synthes | today.reuters.com
- Smith and Nephew's patent on intramedullary hip screws was upheld.
- However, it is difficult to enforce and Synthes has not taken any products off of the market. -
Surgery for herniated lumbar disc
December 11, 2006
For Herniated Lumbar Disk, Medical Therapy Matches Surgery | www.medpagetoday.com
To evaluate further the role of surgery vs. medical treatment.
-
MCAC meeting not likely to result in reimbursement changes
December 8, 2006
Is CMS Setting the Stage to Deny Coverage for Spine Fusion | www.ryortho.com
The current data regarding efficacy of spinal fusion does not justify any changes in clinical practice.
There is insufficient data, new or old, to change reimbursement patterns for spinal surgery.
The publication of the SPORT study (the fusion cohort of patients) in the next two years may help shed some light on the issue of spinal fusion efficacy. -
New device from Medtronic to compete with X-STOP interspinous spacer
December 7, 2006
First Patient Enrolled in Medtronic’s Clinical Trial of the DIAM Spinal Stabilization System | wwwp.medtronic.com
Once released on the market, this device will be a major competitor for the X-STOP which was recently approved by the FDA.
There is a large group of patients with mild to moderate lumbar spinal stenosis who might benefit from this technology. -
X-STOP device may play a vital role in spine surgery for lumbar spinal stenosis
December 5, 2006
Spacer Insertion may offer less invasive option for lumbar problems | www.medicalnewstoday.com
The X-STOP device, and other intespinous spacers, may replace conventional surgery for a large number of patients with lumbar spinal stenosis.
More studies, long term follow-up, and comparison to current surgical options will still need to be assessed prior to making spacers standard treatment.
- Subscribe to Updates
-
Leading institutions connect with members of the Healthcare councils through GLG
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 7 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Most Popular Healthcare News
-
What is potential future for Sequenom in prenatal testing.
November 9, 2009
-
November 7, 2009
-
Express Scripts feeling Growing Pains
October 29, 2009
-
CDC Outlines H1N1 Test Guidelines
October 8, 2009
-
Why Health Care Costs Keep Rising—And What to Do About It
September 13, 2009